Biotech

All Articles

8 months after a $213M fundraise, genetics publisher Tome creates decreases

.After raising $213 million in 2023-- among the year's most extensive exclusive biotech rounds-- Tom...

BioMarin develops director team with biotech vets-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our summary of notable leadership hirings, shootings as ...

Biopharma Q2 VC attacked highest level because '22, while M&ampA slowed

.Financial backing backing into biopharma rose to $9.2 billion all over 215 sell the second one-four...

Bicara, Zenas look for IPOs to press late-phase assets toward market

.Bicara Therapies and also Zenas Biopharma have offered new catalyst to the IPO market with filings ...

Genentech to finalize cancer cells immunology investigation team

.Genentech is going to shut its own cancer immunology study department, and also system mind and als...

Kezar goes down sound growth however to prove its own worth in stage 1 trial

.Kezar Lifestyle Sciences is dropping its unpromising phase 1 sound lump drug as the biotech goes al...

Acelyrin drops izokibep, lays off 3rd of personnel

.Even with izokibep preserving its newly found winning touch in the clinic, Acelyrin is actually no ...

Rivus' stage 2 obesity-related cardiac arrest test hits endpoint

.Rivus Pharmaceuticals has actually plumped up the customers of its own fat-busting, muscle-sparing ...

Ovid standstills preclinical job, IV course after soticlestat stop working

.Ovid Therapeutics already uncovered last month that it was trimming its headcount as the provider g...

Eli Lilly opens up $700M nucleic acid R&ampD center in Boston Seaport

.Eli Lilly has actually opened up a $700 thousand R&ampD center in the Boston Seaport, enhancing its...